Literature DB >> 19002911

An oriP expression vector containing the HIV-1 Tat/TAR transactivation axis produces high levels of protein expression in mammalian cells.

M S Cho1, H Yee, C Brown, K T Jeang, S Chan.   

Abstract

A mammalian gene expression vector based on cytomegalovirus (CMV)enhancer/promoter (CMVe/p) for the regulation of gene expression was further optimized by adding oriP elements derived from Epstein-Barr virus (EBV) and the Tat/TAR transactivation axisfrom human immunodeficiency virus type 1 (HIV-1). Using the Tat/TAR-oriP expression vector, a transient transfection system was optimized for an extended culture period to produce large amounts of secreted IL-2SA (an IL-2 mutein) in HKB11 cells. We observed a 4-fold increase in IL-2SA expression in cells transfected with vectors containing the HIV-1 transactivation axis (Tat/TAR) or oriP elements alone when compared to cells transfected with the control vector having a CMVe/p. Cells transfected with expression vectors equipped with both oriP and Tat/TAR showed an 18-fold increase in IL-2SA expression. This transient transfection system maintained high secretion of IL-2SA for a period of 10-day with no appreciable loss in expression. We demonstrate that during this 10-day culture period, it was possible to produce 1-100 mg of proteins using 500 mug of plasmid DNA.

Entities:  

Year:  2001        PMID: 19002911      PMCID: PMC3449967          DOI: 10.1023/A:1016124911071

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  14 in total

1.  The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent.

Authors:  S Kenney; J Kamine; E Holley-Guthrie; E C Mar; J C Lin; D Markovitz; J Pagano
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

2.  Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element.

Authors:  J M Cherrington; E S Mocarski
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Promiscuous trans activation of gene expression by an Epstein-Barr virus-encoded early nuclear protein.

Authors:  P M Lieberman; P O'Hare; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

4.  Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus.

Authors:  B M Peterlin; P A Luciw; P J Barr; M D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target.

Authors:  B Berkhout; R H Silverman; K T Jeang
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

6.  Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.

Authors:  G Cachianes; C Ho; R F Weber; S R Williams; D V Goeddel; D W Leung
Journal:  Biotechniques       Date:  1993-08       Impact factor: 1.993

7.  Construction of new amplifier expression vectors for high levels of IL-2 gene expression.

Authors:  T C Tsang; J L Brailey; F H Vasanwala; R S Wu; F Liu; P R Clark; L Meade-Tollin; L Luznick; A T Stopeck; E T Akporiaye; D T Harris
Journal:  Int J Mol Med       Date:  2000-03       Impact factor: 4.101

8.  A genetic element that increases the frequency of gene amplification.

Authors:  J G McArthur; C P Stanners
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

9.  Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells.

Authors:  M Rabson; L Heston; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.

Authors:  H E Gendelman; W Phelps; L Feigenbaum; J M Ostrove; A Adachi; P M Howley; G Khoury; H S Ginsberg; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  2 in total

1.  Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells.

Authors:  Chaoting Liu; Brian Dalby; Weixing Chen; Jennifer M Kilzer; Henry C Chiou
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

2.  Blood Clotting Factor VIII: From Evolution to Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov; A I Vorobiev
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.